Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Methods Mol Biol ; 2381: 97-112, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34590272

RESUMO

Genetic perturbation assays have been crucial to the discovery of molecular pathways that drive diverse biological processes. RNA interference (RNAi)-mediated depletion of gene products represents a powerful means of elucidating gene function, as it allows one to systematically probe the phenotypic effects resulting from the functional loss of specific targets. The relative ease of use of RNAi technologies in cultured cells has allowed the design and implementation of genome-wide investigations to systematically reveal gene function. In this chapter, we describe methods for high-throughput RNAi-mediated loss-of-function studies in cultured cells of Drosophila melanogaster. First, we describe the in vitro synthesis of double stranded RNAs (dsRNAs) from a genome-wide Drosophila RNAi library. Next, we outline the procedures used to carry out high-throughput RNAi screens using a cell bathing approach and high-content screening microscopy, illustrating how these experiments can be utilized to study specific cellular contexts, such as cellular stress. Finally, we illustrate some approaches commonly employed to validate the depletion of identified gene candidates.


Assuntos
Drosophila melanogaster , Animais , Células Cultivadas , Drosophila melanogaster/genética , Interferência de RNA , RNA de Cadeia Dupla/genética
2.
Genome Res ; 29(11): 1816-1825, 2019 11.
Artigo em Inglês | MEDLINE | ID: mdl-31519740

RESUMO

RNA sequencing (RNA-seq) is a sensitive and accurate method for quantifying gene expression. Small samples or those whose RNA is degraded, such as formalin-fixed paraffin-embedded (FFPE) tissue, remain challenging to study with nonspecialized RNA-seq protocols. Here, we present a new method, Smart-3SEQ, that accurately quantifies transcript abundance even with small amounts of total RNA and effectively characterizes small samples extracted by laser-capture microdissection (LCM) from FFPE tissue. We also obtain distinct biological profiles from FFPE single cells, which have been impossible to study with previous RNA-seq protocols, and we use these data to identify possible new macrophage phenotypes associated with the tumor microenvironment. We propose Smart-3SEQ as a highly cost-effective method to enable large gene expression profiling experiments unconstrained by sample size and tissue availability. In particular, Smart-3SEQ's compatibility with FFPE tissue unlocks an enormous number of archived clinical samples; combined with LCM it allows unprecedented studies of small cell populations and single cells isolated by their in situ context.


Assuntos
Perfilação da Expressão Gênica/métodos , Microdissecção e Captura a Laser/métodos , Análise de Sequência de RNA/métodos , Análise de Célula Única/métodos , Humanos , Macrófagos/metabolismo , Reprodutibilidade dos Testes , Microambiente Tumoral
3.
Neuron ; 103(5): 802-819.e11, 2019 09 04.
Artigo em Inglês | MEDLINE | ID: mdl-31272829

RESUMO

Stress granules (SGs) form during cellular stress and are implicated in neurodegenerative diseases such as amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD). To yield insights into the role of SGs in pathophysiology, we performed a high-content screen to identify small molecules that alter SG properties in proliferative cells and human iPSC-derived motor neurons (iPS-MNs). One major class of active molecules contained extended planar aromatic moieties, suggesting a potential to intercalate in nucleic acids. Accordingly, we show that several hit compounds can prevent the RNA-dependent recruitment of the ALS-associated RNA-binding proteins (RBPs) TDP-43, FUS, and HNRNPA2B1 into SGs. We further demonstrate that transient SG formation contributes to persistent accumulation of TDP-43 into cytoplasmic puncta and that our hit compounds can reduce this accumulation in iPS-MNs from ALS patients. We propose that compounds with planar moieties represent a promising starting point to develop small-molecule therapeutics for treating ALS/FTD.


Assuntos
Esclerose Lateral Amiotrófica/metabolismo , Grânulos Citoplasmáticos/efeitos dos fármacos , Proteínas de Ligação a DNA/efeitos dos fármacos , Demência Frontotemporal/metabolismo , Neurônios Motores/efeitos dos fármacos , Agregação Patológica de Proteínas/metabolismo , Bibliotecas de Moléculas Pequenas/farmacologia , Estresse Fisiológico/efeitos dos fármacos , Linhagem Celular , Grânulos Citoplasmáticos/metabolismo , DNA Helicases/genética , Proteínas de Ligação a DNA/metabolismo , Células HEK293 , Ribonucleoproteínas Nucleares Heterogêneas Grupo A-B/metabolismo , Ensaios de Triagem em Larga Escala , Humanos , Células-Tronco Pluripotentes Induzidas , Proteínas Intrinsicamente Desordenadas , Neurônios Motores/metabolismo , Células-Tronco Neurais/efeitos dos fármacos , Células-Tronco Neurais/metabolismo , Proteínas de Ligação a Poli-ADP-Ribose/genética , RNA Helicases/genética , Proteínas com Motivo de Reconhecimento de RNA/genética , Proteína FUS de Ligação a RNA/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...